Searching... Searching...
  • NVP + 4.45%
  • Köp 5.34
  • Sälj 5.39
  • Senast 5.40
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

IR contact

NeuroVive Pharmaceutical AB intends to provide the financial markets with accurate, consistent and relevant information on the company on a regular basis.

In the first instance, IR-related issues should be addressed to the IR Director.

Catharina Johansson, CFO
E-mail: ir@neurovive.com
Tel: +46 [0] 46-275 62 21

Comments are closed.

  • Press Releases

    NeuroVive’s genetic mitochondrial disease drug candidate KL1333 mechanism of action published in scientific journal 06 July Lund, Sweden and Seoul, Korea, 6 July 2018 – NeuroVive ... Read More